Source:http://linkedlifedata.com/resource/pubmed/id/10993782
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
3
|
pubmed:dateCreated |
2000-10-12
|
pubmed:abstractText |
Cardiac sarcolemmal Na(+)/H(+) exchange is critical for the regulation of intracellular pH, and its activity contributes to ischemia-reperfusion injury. It has been suggested that the membrane phospholipid environment does not modulate Na(+)/H(+) exchange. The present study was carried out to determine the effects on Na(+)/H(+) exchange of modifying the endogenous membrane phospholipids through the addition of exogenous phospholipase D. Incubation of 0.825 U of phospholipase D with 1 mg of porcine cardiac sarcolemmal vesicles hydrolyzed 34 +/- 2% of the sarcolemmal phosphatidylcholine and increased phosphatidic acid 10.2 +/- 0.5-fold. Treatment of vesicles with phospholipase D resulted in a 46 +/- 2% inhibition of Na(+)/H(+) exchange. Na(+)/H(+) exchange was measured as a function of reaction time, extravesicular pH, and extravesicular Na(+). All of these parameters of Na(+)/H(+) exchange were inhibited following phospholipase D treatment compared with untreated controls. Passive efflux of Na(+) was unaffected. Treatment of sarcolemmal vesicles with phospholipase C had no effect on Na(+)/H(+) exchange. We conclude that phospholipase D-induced changes in the cardiac sarcolemmal membrane phospholipid environment alter Na(+)/H(+) exchange.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical |
http://linkedlifedata.com/resource/pubmed/chemical/Membrane Lipids,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidic Acids,
http://linkedlifedata.com/resource/pubmed/chemical/Phosphatidylcholines,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipase D,
http://linkedlifedata.com/resource/pubmed/chemical/Phospholipids,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium,
http://linkedlifedata.com/resource/pubmed/chemical/Sodium-Hydrogen Antiporter,
http://linkedlifedata.com/resource/pubmed/chemical/growth factor-activatable Na-H...
|
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0363-6135
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
279
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
H1179-84
|
pubmed:dateRevised |
2006-11-15
|
pubmed:meshHeading |
pubmed-meshheading:10993782-Animals,
pubmed-meshheading:10993782-Dose-Response Relationship, Drug,
pubmed-meshheading:10993782-Hydrogen-Ion Concentration,
pubmed-meshheading:10993782-Intracellular Membranes,
pubmed-meshheading:10993782-Ion Transport,
pubmed-meshheading:10993782-Membrane Lipids,
pubmed-meshheading:10993782-Myocardium,
pubmed-meshheading:10993782-Organelles,
pubmed-meshheading:10993782-Permeability,
pubmed-meshheading:10993782-Phosphatidic Acids,
pubmed-meshheading:10993782-Phosphatidylcholines,
pubmed-meshheading:10993782-Phospholipase D,
pubmed-meshheading:10993782-Phospholipids,
pubmed-meshheading:10993782-Sarcolemma,
pubmed-meshheading:10993782-Sodium,
pubmed-meshheading:10993782-Sodium-Hydrogen Antiporter,
pubmed-meshheading:10993782-Swine
|
pubmed:year |
2000
|
pubmed:articleTitle |
Altered cardiac Na(+)/H(+) exchange in phospholipase D-treated sarcolemmal vesicles.
|
pubmed:affiliation |
Division of Stroke and Vascular Disease, St. Boniface General Hospital Research Centre, Winnipeg, Manitoba, Canada R2H 2A6.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|